By Counterforce Health Team in Dojolvi (triheptanoin) —

How to Get Dojolvi (Triheptanoin) Covered by UnitedHealthcare in Illinois: Complete Appeal Guide with Forms and Timelines

Answer Box: Getting Dojolvi Covered by UnitedHealthcare in Illinois

UnitedHealthcare requires prior authorization for Dojolvi (triheptanoin) with molecular confirmation of LC-FAOD and discontinuation of MCT oil. If denied, Illinois residents have strong appeal rights including internal appeals (180 days) and external review (4 months from final denial). Start today: 1) Request peer-to-peer review with UnitedHealthcare medical director, 2) Gather genetic testing results and prior therapy documentation, 3) Submit appeal through UnitedHealthcare provider portal or call 866-889-8054. Illinois Department of Insurance provides free consumer assistance at (866) 445-5364.

Table of Contents

Coverage Requirements at a Glance

Requirement What It Means Where to Find It Source
Prior Authorization Must get approval before filling prescription UnitedHealthcare provider portal UHC PA Requirements
Molecular Confirmation Genetic testing showing LC-FAOD mutations (CPT2, ACADVL, HADHA, HADHB) Lab reports from certified genetics lab OptumRx PA Criteria
MCT Oil Discontinuation Stop all medium-chain triglyceride products before starting Dojolvi Provider attestation in PA request OptumRx PA Criteria
Specialist Prescription From board-certified geneticist, endocrinologist, or metabolic specialist Provider credentials verification Dojolvi PA Guidelines
12-Month Authorization Initial approval valid for one year PA approval letter OptumRx PA Criteria

Step-by-Step: Fastest Path to Approval

1. Gather Required Documentation (Patient/Family)

  • Insurance card and member ID
  • Complete genetic testing results showing LC-FAOD mutations
  • Records of all prior MCT oil trials and outcomes
  • Current metabolic specialist contact information
  • Timeline: 1-2 days to collect

2. Provider Submits Prior Authorization (Clinic)

  • Submit through UnitedHealthcare Provider Portal or call 866-889-8054
  • Include molecular confirmation, specialist consultation, and MCT discontinuation plan
  • Timeline: Same day submission possible

3. UnitedHealthcare Review Process

  • Standard review: 15 business days maximum
  • Expedited review (if medically urgent): 72 hours
  • Decision notification: Written notice to both patient and provider

4. If Denied: Request Peer-to-Peer Review (Provider)

  • Call UnitedHealthcare medical director within 48 hours of denial
  • Use clinical talking points focusing on genetic confirmation and failed alternatives
  • Timeline: Usually scheduled within 24-48 hours

5. Submit Internal Appeal if Needed (Patient or Provider)

  • Must file within 180 days of denial in Illinois
  • Include all supporting clinical documentation
  • Decision timeline: 15 business days (24 hours if expedited)

6. External Review Through Illinois DOI (Patient)

  • File within 4 months of final internal denial
  • Contact Illinois Department of Insurance at (866) 445-5364
  • Review timeline: 5 business days after reviewer receives records

7. Utilize Support Resources

  • Contact Counterforce Health for expert appeal assistance
  • Apply for manufacturer patient assistance programs
  • Timeline: Ongoing support available

Reading Your Denial Letter

Your UnitedHealthcare denial will include specific reason codes. Here's how to decode them:

Most Common Dojolvi Denial Reasons:

  • "Molecular confirmation not provided" → Submit genetic testing results showing pathogenic mutations
  • "Concurrent MCT use" → Provide attestation that MCT oil has been discontinued
  • "Not prescribed by specialist" → Include credentials of metabolic specialist
  • "Quantity limits exceeded" → Justify dosing based on patient weight and caloric needs
Tip: Look for the "Clinical Criteria Not Met" section—this tells you exactly what documentation UnitedHealthcare needs to approve your appeal.

Common Denial Reasons & How to Fix Them

Denial Reason Required Fix Documents Needed
Missing molecular confirmation Submit genetic testing results Lab report showing LC-FAOD mutations in CPT2, ACADVL, HADHA, or HADHB genes
Concurrent MCT oil use Provider attestation of MCT discontinuation Letter from prescriber confirming all MCT products stopped
Non-specialist prescriber Specialist consultation or referral Documentation from board-certified geneticist or metabolic specialist
Insufficient prior therapy documentation Medical necessity letter with treatment history Records of dietary management attempts and outcomes
Quantity limit concerns Dosing justification based on patient needs Weight-based dosing calculation and caloric intake assessment

Appeals Playbook for Illinois

Internal Appeal Process

Level 1: Standard Internal Appeal

  • Deadline: 180 days from denial date
  • Submit to: UnitedHealthcare appeals department via provider portal or fax
  • Required documents: Appeal letter, clinical records, genetic testing, specialist notes
  • Decision timeline: 15 business days (24 hours if expedited)

Expedited Appeals

  • Available when delay would significantly increase health risks
  • Decision timeline: 24 hours for urgent pre-service requests
  • Request by calling UnitedHealthcare and stating "expedited appeal needed"

External Review in Illinois

If your internal appeal is denied, Illinois law guarantees your right to independent external review:

Filing Requirements:

Review Process:

  • Independent physician reviewer with LC-FAOD expertise
  • Decision timeline: 5 business days after reviewer receives complete records
  • Binding decision: UnitedHealthcare must cover if reviewer approves
Illinois Advantage: The state's external review process is faster than most, with decisions in about 30 days total from your request.

Medical Necessity Letter Checklist

For Prescribers: Essential Elements

Patient Information

  • ✅ Confirmed LC-FAOD diagnosis with specific genetic mutations
  • ✅ ICD-10 codes: E71.310 (Long chain/very long chain acyl CoA dehydrogenase deficiency)
  • ✅ Age, weight, and current nutritional status

Clinical Justification

  • ✅ Molecular confirmation: "Genetic testing confirms pathogenic mutations in [specific gene]"
  • ✅ Prior therapy failures: "Patient experienced [specific outcomes] with MCT oil therapy"
  • ✅ Medical necessity: "Dojolvi provides essential anaplerotic substrates not available through dietary management alone"
  • ✅ Dosing rationale: "Prescribed at [X]% of daily caloric intake based on FDA labeling"

Supporting Evidence

  • ✅ FDA approval for LC-FAOD: FDA Access Data
  • ✅ Clinical guidelines from metabolic specialists
  • ✅ Documentation of MCT oil discontinuation plan

Contraindications to Alternatives

  • ✅ "MCT oil alone insufficient for metabolic demands"
  • ✅ "Patient requires odd-chain fatty acids provided uniquely by triheptanoin"
  • ✅ "No FDA-approved alternatives exist for LC-FAOD"

Cost Savings and Support Programs

Manufacturer Support

Ultragenyx Patient Assistance

  • Financial assistance for eligible patients
  • Copay support programs available
  • Contact: 1-833-ULTRA-1 or visit Ultragenyx patient support website

Foundation Grants

  • National Organization for Rare Disorders (NORD): Rare disease medication assistance
  • HealthWell Foundation: Copay assistance for chronic conditions
  • Patient Access Network Foundation: Specialty medication support

Illinois-Specific Resources

  • Illinois Department of Healthcare and Family Services: Medicaid coverage options
  • Illinois Attorney General Health Care Helpline: 1-877-305-5145 for insurance assistance
From Our Advocates: "We've seen patients reduce Dojolvi costs from over $6,000 per bottle to under $50 monthly by combining manufacturer copay cards with foundation grants. Start applications early—some programs have waiting lists during high-demand periods."

When to Escalate to State Regulators

Illinois Department of Insurance Assistance

Contact OCHI (Office of Consumer Health Insurance) if:

  • UnitedHealthcare delays appeals beyond legal timelines
  • Denial reasons seem inconsistent with medical evidence
  • You need help navigating the external review process

Contact Information:

Illinois Attorney General

  • Health Care Helpline: 1-877-305-5145
  • Can intervene informally with insurers
  • Particularly helpful for complex rare disease cases

FAQ: UnitedHealthcare Dojolvi Coverage

How long does UnitedHealthcare prior authorization take for Dojolvi in Illinois? Standard review takes up to 15 business days. Expedited review (for urgent medical needs) must be decided within 72 hours. Most approvals come within 5-7 business days when complete documentation is submitted.

What if Dojolvi isn't on my UnitedHealthcare formulary? Dojolvi requires prior authorization but is typically covered as a specialty medication. Non-formulary status can be appealed with medical necessity documentation. Contact OptumRx at 866-889-8054 to verify your specific plan's coverage.

Can I request expedited appeal if I'm already stable on Dojolvi? Expedited appeals are for situations where delays would significantly increase health risks. If you're stable, standard appeal timelines apply (15 business days). However, if you're at risk of metabolic crisis without medication, expedited review is appropriate.

Does step therapy apply if I failed MCT oil in another state? Yes, prior therapy failures from other states count toward UnitedHealthcare's step therapy requirements. Provide complete documentation of previous MCT oil trials and outcomes, regardless of where treatment occurred.

What happens if my external review is approved but UnitedHealthcare still won't pay? External review decisions are legally binding in Illinois. If UnitedHealthcare doesn't comply, contact the Illinois Department of Insurance immediately at (866) 445-5364. The state can enforce compliance and may impose penalties.

How much does Dojolvi cost without insurance? Cash prices typically range from $5,857 to $6,365 per 500-mL bottle. Most patients need multiple bottles monthly, making insurance coverage essential. Manufacturer assistance programs can significantly reduce out-of-pocket costs.

Can my pediatrician prescribe Dojolvi, or does it need a specialist? While any licensed physician can technically prescribe Dojolvi, UnitedHealthcare typically requires prescription from or consultation with a board-certified geneticist, endocrinologist, or metabolic specialist for prior authorization approval.

What if I need Dojolvi while traveling outside Illinois? UnitedHealthcare coverage typically follows you nationwide, but confirm with member services before traveling. Carry copies of your prior authorization approval and prescription. For emergencies, most plans cover urgent fills at out-of-network pharmacies.

Getting expert help with your Dojolvi appeal can significantly improve your chances of approval. Counterforce Health specializes in turning insurance denials into successful appeals by analyzing denial letters, identifying specific coverage criteria, and drafting evidence-based rebuttals tailored to each payer's requirements. Their platform helps patients, clinicians, and specialty pharmacies navigate complex prior authorization and appeals processes, particularly for rare disease medications like Dojolvi where precise documentation and targeted clinical arguments are essential for approval.

Sources & Further Reading

Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Always consult with your healthcare provider about treatment decisions and contact your insurance company or state insurance department for the most current coverage requirements and appeal procedures. Coverage policies and state regulations may change.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.